Hürthle Cell Carcinoma

Author:

Grossman Richard F.1,Clark Orlo H.1

Affiliation:

1. Department of Surgery, University of California, San Francisco/Mount Zion Medical Center, San Francisco, Calif.

Abstract

Background Hürthle cell carcinoma represents approximately 3% of all differentiated thyroid cancers. The terminology is often confusing, and discrimination between Hürthle cell carcinoma and benign Hürthle cell tumors can be unclear. Thus, optimal treatment of patients with these diseases remains unsettled. Methods The authors reviewed published evidence on the presentation, biologic behavior, and treatment outcomes for this disease. In addition, they summarized their experience involving a series of 14 patients with Hürthle cell carcinoma. Results Hürthle cell carcinoma generally produces thyroglobulin and rarely takes up radioactive iodine. It is frequently bilateral or multifocal within the thyroid gland and often presents with local invasion. Hürthle cell carcinoma is associated with a high rate of locoregional recurrence and significant mortality. Conclusions The authors advocate total thyroidectomy with central neck dissection as the therapy of choice for patients with Hürthle cell carcinoma.

Publisher

SAGE Publications

Subject

Oncology,Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3